Xwell, INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NASDAQ
XWEL
Xwell, INCXWELL, Inc. reported a net loss for Q2 2026, announced the sale of its airport operations, and detailed a significant private placement of Series H Convertible Preferred Stock.
NASDAQ
XWEL
Xwell, INCXWELL, Inc. reported recurring losses and substantial doubt about its ability to continue as a going concern, despite securing new senior secured convertible notes and improving operating losses.
NASDAQ
XWEL
Xwell, INCXWELL, Inc. reported a significant increase in net loss and revenue decline for the second quarter and first half of 2025, raising substantial doubt about its ability to continue as a going concern despite regaining Nasdaq compliance.
NASDAQ
XWEL
Xwell, INCXWELL Inc.'s Q1 2025 revenue decreased by 20% year-over-year, driven by lower XpresTest and XpresSpa revenue, while the company addresses going concern doubts and Nasdaq compliance.
NASDAQ
XWEL
Xwell, INC10-Q: XWELL Inc. Reports Third Quarter 2024 Results, Revenue Increases Driven by Testing and Acquisitions
XWELL Inc. saw a revenue increase in Q3 2024, driven by growth in its testing segment and the acquisition of Naples Wax Center, despite an overall operating loss.
NASDAQ
XWEL
Xwell, INC10-Q: XWELL Inc. Reports Second Quarter 2024 Results, Revenue Increases Driven by Testing and Acquisitions
XWELL Inc. saw a revenue increase in the second quarter of 2024, driven by growth in its testing segment and the acquisition of Naples Wax Center, despite an overall operating loss.
NASDAQ
XWEL
Xwell, INC10-Q: XWELL Inc. Reports First Quarter 2024 Results, Revenue Up 24% Driven by XpresTest and Naples Wax
XWELL Inc. saw a 24% increase in revenue in the first quarter of 2024, primarily driven by growth in the XpresTest segment and the addition of Naples Wax Center, despite an overall operating loss.